GN Store Nord A/S, a Danish leader in intelligent audio solutions, has announced a definitive agreement to divest its Hearing business to Amplifon S.p.A., a prominent global hearing care retailer. The landmark transaction, valuing the Hearing business at DKK 17.0 billion (approximately $2.5 billion USD) on a cash-free and debt-free basis, marks a significant consolidation in the global audiology sector, poised to create a new vertically integrated industry leader. The deal, expected to close by the end of 2026, will be settled with DKK 12.6 billion (approximately $1.85 billion USD) in cash and 56 million shares in Amplifon, contingent upon customary regulatory approvals and the successful separation of GN’s Hearing business.
The acquisition represents a strategic pivot for both entities. For Amplifon, it is a transformative move to meet the escalating global demand for advanced hearing care and technology, dramatically expanding its capabilities to deliver integrated solutions across the entire hearing care value chain, from pioneering device development to comprehensive patient care. For GN Store Nord, the divestiture allows a sharpened focus on its thriving audio and video peripherals markets, including enterprise collaboration and gaming products, with a renewed emphasis on technology leadership in sound processing and low-power edge AI.
A New Era of Vertical Integration in Audiology
The convergence of GN Hearing’s robust product development, manufacturing prowess, and deep audiological technology expertise with Amplifon’s expansive global clinical and retail infrastructure is set to forge a vertically integrated player with unparalleled reach and innovation potential. This strategic alignment is designed to offer more comprehensive and seamless solutions, bridging the gap between cutting-edge hearing aid technology and personalized patient services. The combined entity is projected to generate approximately €3.3 billion (around $3.6 billion USD) in annual revenue, operating across more than 100 countries with a formidable workforce exceeding 20,000 employees. This includes over 700 dedicated R&D professionals and a portfolio of more than 2,800 patents, underscoring its significant scale in both hearing technology and direct-to-consumer care.
Amplifon anticipates generating €60-80 million (approximately $65-87 million USD) in run-rate net EBITDA synergies by the end of 2029, primarily through the insourcing of hearing aid volumes, with further efficiencies expected. Based on 2025 results, the newly formed group is projected to achieve an adjusted EBITDA of approximately €830 million (around $900 million USD), signaling strong financial performance and growth prospects.
Strategic Rationale and Market Dynamics
The global hearing care market is experiencing robust growth, driven by an aging global population, increased awareness of hearing health, and rapid advancements in audiological technology. According to the World Health Organization, over 1.5 billion people worldwide experience some degree of hearing loss, a number projected to rise significantly in the coming decades. This demographic shift, coupled with technological innovations like artificial intelligence, enhanced connectivity, and personalized sound amplification, creates a fertile ground for strategic consolidation and vertical integration.
For Amplifon, a company with a 75-year history of pioneering hearing care retail, this acquisition is its most significant to date. Historically, Amplifon has grown through both organic expansion and strategic acquisitions of smaller retail networks. By integrating a major hearing aid manufacturer like GN Hearing, Amplifon gains direct control over the supply chain, from research and development to manufacturing and distribution. This allows for closer alignment between product innovation and customer needs, potentially accelerating the development of tailor-made solutions and improving the overall patient experience. The move also strengthens Amplifon’s competitive position against other vertically integrated players in the market and provides a direct avenue to capitalize on GN Hearing’s established brands and technological legacy.
For GN Store Nord, the divestiture represents a strategic refocusing on its core audio and video peripherals businesses, which include renowned brands like Jabra (for enterprise collaboration) and SteelSeries (for gaming). While GN Hearing has been a significant part of the company’s heritage, the decision reflects a desire to streamline operations, reduce debt, and allocate capital more efficiently to areas with high growth potential and technological leadership. The proceeds from the sale are earmarked for debt reduction, strategic investments in the remaining businesses, and potential capital returns to shareholders, reinforcing GN’s financial stability and enabling it to pursue ambitious goals in its chosen segments, particularly in sound processing and low-power edge AI.
GN Hearing: A Profile of Innovation
GN Hearing, headquartered in Ballerup, Denmark, has been a cornerstone of GN Store Nord’s operations, dedicated to the development, manufacture, and global marketing of advanced hearing aids and related audiological services. Its impressive portfolio includes globally recognized brands such as ReSound, Beltone, Interton, Danavox, and Danalogic, with the Jabra brand also utilized in select over-the-counter (OTC) and prescription hearing solutions.
The business is characterized by its technology-driven approach, boasting vertically integrated operations and a substantial in-house innovation base. GN Hearing operates state-of-the-art manufacturing facilities across Denmark, China, Malaysia, and the United States, including a recently inaugurated site in the U.S., highlighting its global production capabilities. In fiscal year 2025, GN’s Hearing business reported robust financial performance, generating revenue of DKK 7,214 million (approximately $1.05 billion USD) and a pro-forma EBITDA of DKK 1,185 million (approximately $173 million USD), underscoring its significant market presence and operational efficiency. The acquisition encompasses GN’s entire Hearing business, including approximately 5,500 employees globally, all associated brands like ReSound and Beltone, intellectual property, research and development capabilities, manufacturing operations, and the extensive Beltone retail network partnerships. Notably, GN’s financial investment in Nations Benefits LLC is excluded from the transaction.
Leadership Voices on the Transformative Deal
The leadership of both companies articulated a clear vision for the future following this groundbreaking transaction.
Jukka Pekka Pertola, Chairman of GN Store Nord, expressed enthusiasm for the strategic transformation: “We are excited to transform GN into a pure technology company. We have unique positions and capabilities making us well positioned to further grow in the large audio and video peripherals market in a focused way. While we will miss all of our great employees in Hearing, we are proud that we, together with Amplifon, will create an industry leading player in global audiology. We are convinced that the transaction and steps ahead will be beneficial to our customers, employees and investors.”
Peter Karlströmer, CEO of GN Store Nord, echoed this sentiment, emphasizing the dual benefits: “We are today acting on an an opportunity to create a global leader in audiology together with Amplifon. The new company has every chance to develop into an industry leader driving further innovation and success in hearing care. For GN, this also creates an opportunity to further strengthen our position in the large and attractive audio and video peripherals markets. We have unique brands, talents, and capabilities and a rich set of opportunities. We have in the last few years strengthened GN significantly financially and operationally. As we open up this new chapter, we are focused on driving success as an innovative technology company with global reach and scale. This is very exciting for GN’s customers, employees, and investors.”
Amplifon CEO Enrico Vita hailed the acquisition as a pivotal moment for his company: “Today marks a turning point for Amplifon. We are announcing the most transformative acquisition in our 75-year-long history, that will fundamentally change the future of the hearing care industry worldwide and create significant and long-term value for all our stakeholders. With combined revenues of approximately €3.3 billion, a presence in more than 100 countries, a cutting-edge R&D platform, leading manufacturing capabilities, and an unparalleled commercial network, we will be forming a truly global vertically integrated leader in audiology. Importantly, Amplifon will continue to preserve and enhance Hearing’s unique identity, heritage, and strengths, recognizing its brand value, culture, and distinct capabilities as key contributors to the future success of the combined organization. We look forward to working closely with the exceptional team at Hearing to improve hearing health for millions of people globally.”
Broader Implications for the Hearing Care Landscape
This acquisition will undoubtedly reshape the competitive landscape of the global hearing care industry. The creation of a vertically integrated giant, combining manufacturing prowess with extensive retail distribution, puts pressure on other major players such as Sonova, Demant, and WS Audiology to potentially re-evaluate their own strategies. It accelerates a trend towards consolidation and integration that has been observed in the sector for several years, driven by the desire to control the entire customer journey, from product innovation to fitting and aftercare.
For consumers, this could translate into more integrated and personalized hearing solutions, potentially with enhanced technological features and more consistent service quality across a wider geographical footprint. The combined entity’s massive R&D budget and patent portfolio suggest a strong commitment to innovation, which could lead to breakthroughs in hearing aid technology and audiological services. However, market consolidation also raises questions about potential impacts on pricing and choice, which regulatory bodies will likely scrutinize during the approval process.
For shareholders, GN’s move offers a clearer investment thesis in a focused technology company, while Amplifon’s shareholders stand to benefit from significant growth, expanded market leadership, and anticipated synergies. The long lead time to closing (end of 2026) suggests a complex carve-out and integration process, but also allows ample time for meticulous planning and execution.
Transaction Mechanics and Future Outlook
The transaction involves a detailed carve-out process, separating the Hearing business from GN through a statutory demerger under the Danish Companies Act. GN will provide transitional services post-closing to ensure a smooth separation and integration for Amplifon. The deal is subject to customary regulatory approvals across various jurisdictions, reflecting the global nature of the businesses involved.
Upon closing, a shareholders’ agreement is anticipated between GN and Ampliter S.r.l., Amplifon’s controlling shareholder, which will grant GN the right to propose a representative for appointment to Amplifon’s Board of Directors, subject to standard transfer restrictions and lock-up undertakings. This provision underscores GN’s continued strategic interest in the success of the combined audiology entity.
Following the announcement, GN stated that its Hearing division will be classified as discontinued operations, and its 2026 financial guidance will reflect only the Enterprise and Gaming segments. Both companies anticipate one-off costs associated with the separation and integration: GN expects an impact on EBITA in 2026, while Amplifon projects approximately €80 million (around $87 million USD) in integration costs over the two to three years following closing.
The strategic advisors for this monumental transaction included J.P. Morgan Securities plc as exclusive financial advisor to GN, with Gorrissen Federspiel Advokatpartnerselskab and Gianni & Origoni providing legal counsel, and PricewaterhouseCoopers handling due diligence. Amplifon was advised by Goldman Sachs Bank Europe SE, Succursale Italia as sole financial advisor, PedersoliGattai as lead legal advisor, and E&Y for due diligence. Legal advisors for bridge financing included White & Case for Amplifon and Clifford Chance for the bank.
This landmark acquisition by Amplifon of GN Store Nord’s Hearing business is more than just a financial transaction; it is a profound strategic realignment that is set to redefine the competitive landscape and future trajectory of the global hearing care industry, promising a new era of integrated innovation and patient-centric solutions.